Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
48-Hour Action Plan: Liver Failure Signal in Flagship Drug Guiding Principle First The side effect is real, the drug is in 4 million patients, and roughly 500 patients per year may develop liver failure (4M ÷ 8,000). Every day of delay is measured in preventable liver transplants and deaths.Read the full answer
As CEO, my primary fiduciary and ethical duty is to patients, regulators, and long-term shareholder value. The "6-month reporting timeline" cited by legal is almost certainly a misunderstanding of regulatory processes (likely conflating initial adverse event reporting with full label amendment review).Read the full answer